Skip to main content

Can it Ever be Pure Science? Pharmaceuticals, the Pharmaceutical Industry and Biomedical Research in the Twentieth Century

  • Chapter
The Invisible Industrialist

Part of the book series: Science, Technology and Medicine in Modern History ((STMMH))

  • 49 Accesses

Abstract

In his celebrated book The Machine in the Garden, Leo Marx undertook to explore how the myth of an idyllic rural domain was first confronted then incorporated and finally transformed by the reality of industrial technology in early-nineteenth-century America. In a passage referring to Thoreau’s Walden, Marx contrasts the images symbolically in these words:

[M]an-made power, the machine with its fire, smoke and thunder, is juxtaposed to the waters of Walden, remarkable for their depth and purity and a matchless. indescribable color — now light blue, now green, almost always pellucid. The iron horse moves across the surface of the earth; the pond invites the eye below the surface. (Marx 1964, pp. 251)

The more drugs that emerge from programs of blind screening the better. Each new active drug provides us with important research tools. Each new drug is a challenge that opens new fields in the basic medical sciences.

Gilman 1959, p. 348

I would like to thank participants at the conference ‘Des manufactures à la facture des connaissances’ held in Paris in 1994, especially Philippe Pignarre, and at the University of York in 1994 for comments on an earlier version of this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Amsterdamska, O. (1987) ‘Medical and Biological Constraints: Early Research on Variation in Bacteriology’, Social Studies of Science, vol. 17, pp. 657–87.

    Article  Google Scholar 

  • Arbuck, S. G. and Blaylock, B. A. (1995) ‘Taxol: Clinical Results and Current Issues in Development’, in M. Suffness (ed.), Taxol: Science and Applications (Boca Raton, Fla.: CRC Press) pp. 379–415.

    Google Scholar 

  • Avila, J. (1992) ‘Microtubule Functions’, Life Science, vol. 50, pp. 327–34.

    Article  Google Scholar 

  • Brennan, M. B. and Long J. R. (1994) ‘Facts and Figures for Chemical R&D’, Chemical and Engineering News, 22 August, pp. 34–67.

    Google Scholar 

  • Brooks, C. M. (1959) ‘Discovery of the Function of Chemical Mediators in the Transmission of Excitation and Inhibition to Effector Tissues’, in C. M. Brooks and P. F. Cranefield (eds) The Historical Development of Physiological Thought (New York: Hafner) pp. 169–81.

    Google Scholar 

  • Callon, M. (1986)’ Some Elements of a Sociology of Translation: Domestication of the Scallops and the Fishermen of St Brieuc Bay’, in J. Law (ed.), Power, Action and Belief: A New Sociology of Knowledge? (London: Routledge & Kegan Paul) pp. 196–233.

    Google Scholar 

  • Carty, J. J. (1916) ‘The Relation of Pure Science to Industrial Research’, Science, vol. 44, pp. 511–18.

    Article  Google Scholar 

  • Chain, E. B. (1963) ‘Academic and Industrial Contributions to Drug Research’, Journal of the Royal Society of Arts, vol. 111, pp. 856–82.

    Google Scholar 

  • Chandler, A. D., Jr (1990) Scale and Scope: The Dynamics of Industrial Capitalism (Cambridge, Mass: Harvard University Press).

    Google Scholar 

  • Clarke, A. E. (1987) ‘Research Materials and Reproductive Science in the United States, 1910–1940’, in G. L. Geison (ed.), Physiology in the American context (Bethesda, Md.: American Physiological Society) pp. 323–50.

    Google Scholar 

  • Clarke, A. E. and Fujimura, J. H. (1992) The Right Tools for the Job: At Work in Twentieth-Century Life Sciences (Princeton University Press).

    Google Scholar 

  • Cragg, G. M., Schepartz, S. A., Stiffness, M. and Grever, M. R. (1993) ‘The Taxol Supply Crisis: New NCI Policies for Handling the Large-Scale Production of Novel Natural Product Anticancer and Anti-HIV Agents’, Journal of Natural Products, vol. 56, pp. 1657–68.

    Article  Google Scholar 

  • Dale, H. H. (1933) ‘Academic and Industrial Research in the Field of Therapeutics’, Science, vol. 77, pp. 521–7.

    Article  Google Scholar 

  • Day, K. A. and Frisvold, G. B. (1993) ‘Medical Research and Genetic Resources Management: The Case of Taxol’, Contemporary Policy Issues, vol. 11, pp. 1–11.

    Article  Google Scholar 

  • DeFuria, M. D. and Horovitz, Z. (1993) ‘Taxol Commercial Supply Strategy’, Monographs: Journal of the National Cancer Institute, vol. 15, pp. 195–8.

    Google Scholar 

  • Dennis, M. A. (1987) ‘Accounting for Research: New Histories of Corporate Laboratories and the Social History of American Science’, Social Studies of Science, vol. 17, pp. 479–518.

    Article  Google Scholar 

  • Djerassi, C. (1992) The Pill, Pygmy Chimps and Degas’ Horse (New York: Basic Books).

    Google Scholar 

  • Eccles, J. (1959) ‘The Development of Ideas on the Synapse’, in C. M. Brooks and P. F. Cranefield (eds), The Historical Development of Physiological Thought (New York: Hafner) pp. 39–66.

    Google Scholar 

  • Eigsti, O. J. and Dustin, P. Jr (1955) Colchicine — In Agriculture, Medicine, Biology and Chemistry (Ames, Iowa: Iowa State College Press).

    Google Scholar 

  • Fox Keller, E. (1990) ‘Physics and the Emergence of Molecular Biology: A History of Cognitive and Political Synergy’, Journal of the History of Biology, vol. 23, pp. 389–409.

    Article  Google Scholar 

  • Fuchs, D. A. and Johnson, R. K. (1978) ‘Cytologic Evidence that Taxol, an Antineoplastic Agent from Taxus brevifolia, Acts as a Mitotic Poison’, Cancer Treatment Reports, vol. 62, pp. 1219–22.

    Google Scholar 

  • Fujimura, J. H. (1987) ‘Constructing “Do-able” Problem in Cancer Research: Articulating Alignment’, Social Studies of Science, vol. 17, pp. 257–93.

    Article  Google Scholar 

  • Fujimura, J. H. (1988) ‘The Molecular Biological Bandwagon in Cancer Research: Where Social Worlds Meet’, Social Problems, vol. 35, pp. 261–83.

    Article  Google Scholar 

  • Fujimura, J. H. (1992) ‘Crafting Science: Standardized Packages, Boundary Objects, and “Translations”’, in A. Pickering (ed.), Science as Practice and Culture (University of Chicago Press) pp. 168–211.

    Google Scholar 

  • Galambos, L. and Sturchio, J. L. (1992) ‘The Origins of an Innovative Organization: Merck & Co., Inc., 1891–1960’, unpublished paper, in the possession of the author.

    Google Scholar 

  • Gilman, A. (1959) ‘The Contribution of Pharmacodynamics and Pharmacology to Basic Physiological Thought’, in C. M. Brooks and P. F. Cranefield (eds), The Historical Development of Physiological Thought (New York: Hafner) pp. 335–49.

    Google Scholar 

  • Goodman, J. and Walsh, V. (1994) ‘Little and Big Heuristics: Medicine, Chemistry and Pharmaceutical Production in Nineteenth-Century Europe’, unpublished paper, in the possession of the author.

    Google Scholar 

  • Granai, C. O. (1992) ‘Ovarian Cancer — Unrealistic Expectations’, The New England Journal of Medicine, vol. 327, pp. 197–200.

    Article  Google Scholar 

  • Hayes, P. (1987) Industry and Ideology: IG Farben in the Nazi Era (Cambridge University Press).

    Google Scholar 

  • Heymans, C. (1967) ‘Pharmacology in Old and Modern Europe’, Annual Review of Pharmacology vol. 7, pp. 1–13.

    Article  Google Scholar 

  • Hofmann, A. (1970) ‘The Discovery of LSD and Subsequent Investigations on Naturally Occurring Hallucinogens’, in F. J. Ayd and B. Blackwell (eds) Discoveries in Biological Psychiatry (Philadelphia: Lippincott) pp. 91–106

    Google Scholar 

  • Hofmann, A. (1972) ‘Ergot — A Rich Source of Pharmacologically Active Substances’, in T. Swain (ed.), Plants in the Development of Modern Medicine (Cambridge, Mass.: Harvard University Press) pp. 235–60.

    Google Scholar 

  • Hofmann, A. (1983) LSD: My Problem Child (Los Angeles: Tarcher).

    Google Scholar 

  • Holmes, F. A., et al. (1991) ‘Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer’, Journal of the National Cancer Institute, vol. 83, pp. 1797–1805.

    Article  Google Scholar 

  • Homburg, E. (1992) ‘The Emergence of Research Laboratories in the Dyestuffs Industry, 1870–1900’, British Journal for the History of Science, vol. 25, pp. 91–111.

    Article  Google Scholar 

  • Horwitz, S. B., Parness, J., Schiff, P. B. and Manfredi, J. J. (1982) ‘Taxol: A New Probe for Studying the Structure and Function of Microtubules’, Cold Spring Harbor Symposia on Quantitative Biology, vol. 46, pp. 219–26.

    Article  Google Scholar 

  • Hyams, J. S. and Lloyd, C. W. (1994) ‘Preface’, in J. S. Hyams and C. W. Lloyd (eds), Microtubules (New York: Wiley-Liss) pp. xi–xii.

    Google Scholar 

  • Kranakis, E. (1990) ‘Technology, Industry and Scientific Development’, in T. Frängsmyr (ed.), Solomon’s House Revisited: The Organization and Institutionalization of Science (Canton, Mass.: Science History Publications) pp. 133–59.

    Google Scholar 

  • Latour, B. (1988) The Pasteurization of France (Cambridge, Mass.: Harvard University Press).

    Google Scholar 

  • Lenoir, T. (1986) ‘Models and Instruments in the Development of Electrophysiology, 1845–1912’, Historical Studies in the Physical and Biological Sciences, vol. 17, pp. 1–54.

    Article  Google Scholar 

  • Lesch, J. E. (1981) ‘Conceptual Change in an Empirical Science: The Discovery of the First Alkaloids’, Historical Studies in the Physical Sciences, vol. 11, pp. 305–28.

    Article  Google Scholar 

  • Lesch, J. E. (1994) ‘Chemistry and Biomedicine in an Industrial Setting: The Invention of the Sulfa Drugs’, in S. H. Mauskopf (ed.) Chemical Sciences in the Modern World (Philadelphia: University of Pennsylvania Press) pp. 158–215.

    Google Scholar 

  • Liebenau, J. (1984) ‘Industrial R&D in Pharmaceutical Firms in the Early Twentieth Century’, Business History, vol. 26, pp. 329–46.

    Article  Google Scholar 

  • Liebenau, J. (1987) Medical Science and Medical Industry (London: Macmillan).

    Google Scholar 

  • Liebenau, J. (1988) ‘Ethical Business: The Formation of the Pharmaceutical Industry in Britain, France, Germany, and the United States Before 1914’, in R. P. T. Davenport-Hines and G. Jones (eds), The End of Insularity: Essays in Comparative Business History (London: Frank Cass) pp. 116–29.

    Google Scholar 

  • Liebenau, J. (1990) ‘Evolution of the Pharmaceutical industry’, in P. D. Kennewell (ed.), Comprehensive Medicinal Chemistry, vol. 1 (Oxford: Pergamon)pp. 81–98.

    Google Scholar 

  • Loudon, I. (1992) Death in Childbirth (Oxford University Press).

    Google Scholar 

  • Lythgoe, B. (1967) ‘The Taxus alkaloids’, in R. H. F. Manske and H. L. Holmes (eds) The Alkaloids: Chemistry and Pharmacology, vol. 10 (Orlando, Fla.: Academic Press) pp. 597–626.

    Google Scholar 

  • McGuire, W. P., Rowinsky, E. K., Rosenhein, N. B. et al. (1989) ‘Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms’, Annals of Internal Medicine, vol. 111, pp. 273–9.

    Article  Google Scholar 

  • Manfredi, J. J. and Horwitz, S. B. (1984) ‘Taxol: An Anitmitotic Agent with a New Mechanism of Action’, Pharmacology and Therapeutics, vol. 25, pp. 83–125.

    Article  Google Scholar 

  • Marcus, A. I. (1990) ‘From Ehrlich to Waksman: Chemotherapy and the Seamed Web of the Past’, in E. Garber (ed.), Beyond History of Science: Essays in Honor of Robert E. Schofield (Bethlehem, Pa.: Lehigh University Press) pp. 266–83.

    Google Scholar 

  • Marks, H. M. (1992) ‘Cortisone, 1949: A Year in the Political Life of a Drug’, Bulletin of the History of Medicine, vol. 66, pp. 419–39.

    Google Scholar 

  • Marx, L. (1964) The Machine in the Garden (New York: Oxford University Press).

    Google Scholar 

  • Meyer-Thurow, G. (1982) ‘The Industrialization of Invention: A Case Study from the German Chemical Industry’, Isis, vol. 73, pp. 363–81.

    Article  Google Scholar 

  • Miller, R. W. (1980) ‘A Brief Survey of Taxus Alkaloids and Other Taxane Derivatives’, Journal of Natural Products, vol. 43, pp. 425–37.

    Article  Google Scholar 

  • Moir, C. (1932) ‘The Action of Ergot Preparations on the Puerperal Uterus’, British Medical Journal, vol. 1, pp. 1119–22.

    Article  Google Scholar 

  • Moir, C. (1974) ‘Ergot: From St Anthony’s Fire to the Isolation of Its Active Principle, Ergometrine (Ergonovine)’, American Journal of Obstetrics and Gynecology, vol. 120, pp. 291–6.

    Google Scholar 

  • Oudshoorn, N. (1990) ‘On the Making of Sex Hormones: Research Materials and the Production of Knowledge’, Social Studies of Science, vol. 20, pp. 5–33.

    Article  Google Scholar 

  • Oudshoorn, N. (1993) ‘United We Stand: The Pharmaceutical Industry, Laboratory, and Clinic in the Development of Sex Hormones into Scientific Drugs, 1920–1940’, Science, Technology, & Human Values, vol. 18, pp. 5–24.

    Article  Google Scholar 

  • Parascandola, J. (1975) ‘Arthur Cushny, Optical Isomerism, and the Mechanism of Drug Action’, Journal of the History of Biology, vol. 8, pp. 145–65.

    Article  Google Scholar 

  • Parascandola, J. (1982) ‘The Search for the Active Oxytocic Principle of Ergot: Laboratory Science and Clinical Medicine in Conflict’, in E. Hickel and G. Schröder (eds) Neue Beiträge zur Arzneimittelgeschichte: Festschrift für Wolfgang Schneider zum 70. Geburtstag. Veröffentlichungen der Internationalen Gesselschaft für Geschichte der Pharmazie, vol. 51 (Stuttgart: Wissenschaftliche Verlagsgesellschaft) pp. 205–27.

    Google Scholar 

  • Parascandola, J. (1985) ‘Industrial Research Comes of Age: The American Pharmaceutical Industry, 1920–1940’, Pharmacy in History, vol. 27, pp. 12–21.

    Google Scholar 

  • Pavitt, K. (1997) ‘Academic Research, Technical Change and Government Policy’, in J. Krige and D. Pestre (eds), Science in the Twentieth Century (Reading: Harwood) pp. 143–158.

    Google Scholar 

  • Pickstone, J. V. (1993a) ‘The Biographical and the Analytical. Towards a Historical Model of Science and Practice in Modern Medicine’, in I. Löwy (ed.), Medicine and Change: Historical and Sociological Studies of Medical Innovation (Paris: Les Editions INSERM/John Libbey) pp. 23–47.

    Google Scholar 

  • Pickstone, J. V. (1993b) ‘Ways of Knowing: Towards a Historical Sociology of Science, Technology and Medicine’, British Journal for the History of Science, vol. 26, pp. 433–58.

    Article  Google Scholar 

  • Rabkin, Y. M. (1987) ‘Technological Innovation on Science: The Adoption of Infrared Spectroscopy by Chemists’, Isis, vol. 78, pp. 31–54.

    Article  Google Scholar 

  • Rosenberg, N. and Nelson, R. R. (1994) ‘American Universities and Technical Advance in Industry’, Research Policy, vol. 23, pp. 323–48.

    Article  Google Scholar 

  • Rowinsky, E. K. and Donehower, R. C. (1991) ‘Taxol: Twenty Years Later, the Story Unfolds’, Journal of the National Cancer Institute, vol. 83, pp. 1778–81.

    Article  Google Scholar 

  • Schepartz, S. A. (1976) ‘History of the National Cancer Institute and the Plant Screening Program’ Cancer Treatment Reports, vol. 60, pp. 975–7.

    Google Scholar 

  • Schiff, P. B., Fant, J. and Horwitz, S. B. (1979) ‘Promotion of Microtubule Assembly in vitro by Taxol’, Nature, vol. 277, pp. 665–7.

    Article  Google Scholar 

  • Schiff and Horwitz, S. B. (1981) ‘Taxol Assembles Tubulin in the Absence of Exogenous Guanosine 5′-Triphosphate or Microtubule-Associated Proteins’, Biochemistry, vol. 20, pp. 3247–52.

    Article  Google Scholar 

  • Schmidt, C. F. (1961) ‘Pharmacology in a Changing World’, Annual Review of Physiology, vol. 23, pp. 1–13.

    Article  Google Scholar 

  • Sessoms, S. M. (1960) ‘Review of the Cancer Chemotherapy National Service Center Program’, Cancer Chemotherapy Reports, vol. 7, pp. 25–8.

    Google Scholar 

  • Smith, J. K. Jr (1990) ‘The Scientific Tradition in American Industrial Research’, Technology and Culture, vol. 31, pp. 121–31.

    Article  Google Scholar 

  • Sneader, W. (1985) Drug Discovery: The Evolution of Modern Medicines (Chichester: Wiley).

    Google Scholar 

  • Snyder, J. A. and Mullins, J. M. (1993) ‘Analysis of Spindle Microtubule Organization in Untreated and Taxol-Treated PtK1 Cells’, Cell Biology International, vol. 17, pp. 1075–84.

    Article  Google Scholar 

  • Swann, J. P. (1989) ‘Biomedical Research and Government Support: The case of Drug Development’, Pharmacy in History, vol. 31, pp. 103–16.

    Google Scholar 

  • Suffness, M. (1994) ‘Is Taxol a Surrogate for a Universal Regulator of Mitosis’, In Vivo, vol. 8, pp. 867–78.

    Google Scholar 

  • Suffness, M. and Wall, M. E. (1995) ‘Discovery and Development of Taxol’, in M. Suffness (ed.), Taxol: Science and Applications (Boca Raton, Fla: CRC Press) pp. 3–25.

    Google Scholar 

  • Swann, J. P. (1988) Academic Scientists and the Pharmaceutical Industry (Baltimore, Md.: Johns Hopkins University Press).

    Google Scholar 

  • Tansey, E. M. and Milligan, R. C. E. (1990) ‘The Early History of the Wellcome Research Laboratories, 1894–1914’ in G. J. Higby and E. C. Stroud (eds), Pill Peddlers: Essays on the History of the Pharmaceutical Industry (Madison, WI: American Institute of the History of Pharmacy) pp. 91–106.

    Google Scholar 

  • Travis, A. S. (1989)’ Science as Receptor of Technology: Paul Ehrlich and the Synthetic Dyestuffs Industry’, Science in Context, vol. 3, pp. 383–408.

    Article  Google Scholar 

  • Ulrich, R. F. and Pattern, B. M. (1991) ‘The Rise, Decline, and Fall of LSD’, Perspectives in Biology and Medicine, vol. 34, pp. 561–78.

    Article  Google Scholar 

  • Vallee, R. B. (1982) ‘Taxol Dependent Procedure for the Purification of Microtubules and MAPs’, Journal of Cell Biology, vol. 92, pp. 435–42.

    Article  Google Scholar 

  • Vallee, R. B. (1995) ‘The Use of taxol in Cell Biology’, in M. Suffness (ed.), Taxol: Science and Applications (Boca Raton, Fla.: CRC Press) pp. 259–74.

    Google Scholar 

  • Wainwright, M. (1991) ‘Streptomycin: Discovery and Resultant Controversy’, History and Philosophy of the Life Sciences, vol. 13, pp. 97–124.

    Google Scholar 

  • Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P. and McPhail, A. T. (1971) ‘Plant Antitumor Agents. VI. The Isolation and Structure of Taxol, a Novel Antileukemic and Antitumor Agent from Taxus brevifoliaJournal of the American Chemical Society, vol. 93, pp. 2325–7.

    Article  Google Scholar 

  • Weatherall, M. (1990) In Search of a Cure: A history of Pharmaceutical Discovery (Oxford University Press).

    Google Scholar 

  • Wilson, L. and Jordan, M. A. (1994) ‘Pharmacological Probes of Microtubule Function’, in J. S. Hyams and C. W. Lloyd (eds) Microtubules (New York: Wiley-Liss) pp. 59–83.

    Google Scholar 

  • Youngken, H. W. (1947) ‘Ergot — A Blessing and a Scourge’, Economic Botany, vol. 1, pp. 372–80.

    Article  Google Scholar 

  • Zubrod, C. G. (1984) ‘Origins and Development of Chemotherapy Research at the National Cancer Institute’, Cancer Treatment Reports, vol. 68, pp. 9–19.

    Google Scholar 

  • Zubrod, C. G., Schepartz, S., Leiter, J. et al. (1966) ‘The Chemotherapy Program of the National Cancer Institute: History, Analysis and Plans’, Cancer Chemotherapy Reports, vol. 50, pp. 349–82.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Copyright information

© 1998 Macmillan Press Ltd

About this chapter

Cite this chapter

Goodman, J. (1998). Can it Ever be Pure Science? Pharmaceuticals, the Pharmaceutical Industry and Biomedical Research in the Twentieth Century. In: Gaudillière, JP., Löwy, I. (eds) The Invisible Industrialist. Science, Technology and Medicine in Modern History. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-26443-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-26443-8_6

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-1-349-26445-2

  • Online ISBN: 978-1-349-26443-8

  • eBook Packages: Palgrave History CollectionHistory (R0)

Publish with us

Policies and ethics